The National Institutes of Health (NIH) is by far the principal nonprofit funder of biomedical research in the United States. Consequently, when President Donald Trump’s fiscal year 2018 budget proposal included deep cuts in funding for the NIH, it sent shock waves through academic medical institutions that benefit from NIH research moneys. Although Congress is unlikely to accommodate this proposal, the suggested cuts raise the question of the role of government in medical innovation.
